Inflammatory Bowel Disease (IBD) remains a significant clinical challenge, requiring effective long-term management strategies. This session on “Real World Experience of Vedolizumab – Indian Phase 4 Data” will highlight practical insights from Indian clinical experience, focusing on treatment outcomes, safety, and real-world applicability of Vedolizumab in IBD management. Led by Dr. Shrikant, the discussion is designed for IBD specialists, gastroenterologists, and general medicine practitioners.